The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Minimally Invasive Treatment Of Lung Cancer Market Expected To Scale Between 2026 And 2030?
The minimally invasive treatment of lung cancer market size has experienced robust growth in recent years. This market is projected to expand from $3.35 billion in 2025 to $3.67 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.5%. The historical growth in this sector can be attributed to several factors, including increasing lung cancer incidence rates, the expansion of oncology treatment centers, advancements in interventional radiology techniques, the rising availability of minimally invasive treatment options, and the growing clinical acceptance of ablation therapies.
The market for minimally invasive treatment of lung cancer is expected to experience significant expansion in the coming years. It is projected to reach $5.21 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.2%. This anticipated growth during the forecast period is driven by factors such as increasing investments in precision cancer care, the rising adoption of robotic and AI-assisted oncology treatments, the expansion of early-stage lung cancer detection programs, a growing demand for outpatient cancer procedures, and an increasing focus on personalized treatment pathways. Dominant trends during this period are anticipated to include the rising adoption of image-guided tumor ablation techniques, an increased use of minimally invasive embolization procedures, the growing integration of robotic assistance in oncology care, the expansion of precision oncology treatment platforms, and an enhanced focus on reducing treatment-related complications.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27349&type=smp
Which Drivers Are Supporting The Minimally Invasive Treatment Of Lung Cancer Market Growth?
The growing incidence of lung cancer is projected to drive the expansion of the minimally invasive treatment of lung cancer market. This form of cancer, characterized by uncontrolled cell growth originating in the lungs, is primarily increasing due to heightened tobacco smoking, which boosts the likelihood of abnormal cell proliferation and tumor development. Minimally invasive treatments assist lung cancer patients by precisely targeting, removing, or destroying tumors via small incisions or imaging-guided probes, thereby shortening recovery periods, reducing harm to healthy lung tissue, lowering complication risks, and enabling a quicker return to normal activities. For instance, in January 2023, a report from the American Cancer Society indicated that an estimated 238,340 individuals (117,550 men and 120,790 women) were anticipated to be diagnosed with lung cancer in 2023, with approximately 127,070 deaths attributed to it. Thus, the escalating prevalence of lung cancer is fueling the growth of the minimally invasive treatment of lung cancer market.
What Are The Main Segments Within The Minimally Invasive Treatment Of Lung Cancer Market Segment Structure?
The minimally invasive treatment of lung cancer market covered in this report is segmented –
1) By Type: Lung Tumor Ablation, Lung Tumor Embolization
2) By Stage: Stage I, Stage II, Stage III, Stage IV
3) By Age Group: Under 30 Years, 31 To 45 Years, 46 To 60 Years
4) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Research Institutions
Subsegments:
1) By Lung Tumor Ablation: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Laser Ablation
2) By Lung Tumor Embolization: Bronchial Artery Embolization, Pulmonary Artery Embolization, Chemoembolization, Radioembolization
Which Trends Are Expected To Impact The Minimally Invasive Treatment Of Lung Cancer Market?
Companies prominent in the minimally invasive treatment of lung cancer market are concentrating on developing innovative offerings, such as microwave ablation systems and navigation-assisted biopsy platforms. This focus aims to address the growing need for lung-sparing treatments, quicker diagnoses, shorter hospital stays, and viable therapy options for individuals unable to undergo open surgery. Microwave ablation (MWA) devices operate by delivering high-frequency electromagnetic energy via a probe to swiftly heat and coagulate tumour tissue, resulting in predictable spherical ablation zones, faster treatment durations, and reduced heat-sink effect compared to radiofrequency ablation. As an illustration, in January 2025, Creo Medical Group plc, a UK-based medical device firm specializing in minimally invasive surgical endoscopy, unveiled the MicroBlate Flex soft-tissue microwave ablation system and initiated its clinical study for lung lesions. The MicroBlate Flex system comprises a microwave generator and a flexible ablation applicator, engineered for diverse soft-tissue applications. It operates by emitting high-frequency microwave energy from its applicator tip to generate controlled thermal zones that eradicate tumour cells. Key attributes of the system include an optimized high-frequency power profile for effective energy deposition, an adaptable delivery design crafted to access challenging anatomical locations, and compatibility with endoscopic or percutaneous approaches. These capabilities facilitate its use in small pulmonary nodules, metastatic lung lesions, and for patients who cannot endure lobectomy. From a clinical perspective, this technology offers benefits such as abbreviated procedure times, a decreased requirement for general anaesthesia, possibilities for outpatient care, and an expanded array of treatment choices when contrasted with conventional open surgery or stereotactic radiotherapy.
Who Are The Companies Participating In The Minimally Invasive Treatment Of Lung Cancer Market?
Major companies operating in the minimally invasive treatment of lung cancer market are Johnson & Johnson, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc., Accuray Incorporated, Richard Wolf GmbH, AngioDynamics Inc., CMR Surgical Ltd., Guangzhou Geyi Medical Instrument Co. Ltd., Quantum Surgical SA, Scanlan International Inc., RZ Medizintechnik GmbH & Co. KG, August Reuchlen GmbH, SBH Surgical GmbH & Co. KG, Geister Medizintechnik GmbH, Cook Medical Incorporated, Terumo Corporation, Merit Medical Systems Inc., Sirtex Medical Limited
Get The Full Minimally Invasive Treatment Of Lung Cancer Market Report:
Which Region Leads The Minimally Invasive Treatment Of Lung Cancer Market In Overall Market Size?
North America was the largest region in the minimally invasive treatment of lung cancer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive treatment of lung cancer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Minimally Invasive Treatment Of Lung Cancer Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Minimally Invasive Treatment Of Lung Cancer Market 2026, By The Business Research Company
Hydrofluoric Acid Market Report 2026
https://www.thebusinessresearchcompany.com/report/hydrofluoric-acid-global-market-report
Electronic Grade Hydrofluoric Acid Market Report
Fluoropolymer Films Market Report
https://www.thebusinessresearchcompany.com/report/fluoropolymer-films-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model